Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Lee J, Ha EJ, Roh J, Kim HK, et al. Presence of TERT +/- BRAF V600E mutation is not a risk factor for the clinical management of patients with papillary thyroid microcarcinoma. Surgery 2021 May 2. pii: S0039-6060(21)00317-2. doi: 10.1016/j.surg.2021.
PMID: 33952391


Privacy Policy